Sites 3 Through 6: One Deep Market or Five Shallow Ones?
For sites 3 through 6, density usually wins. Clustering clinics 20 minutes apart in one metro compounds staffing float pools, 15-to-20-percent faster repeat builds, drivable management, and payer leverage. Spreading into new markets buys a national story but re-runs the first-clinic learning curve every time. Densify to prove unit economics; spread only on a funded national thesis or a real regulatory moat.
Site #2 tested whether you built a system or survived site #1 on brute force. I covered that in The Second Site Paradox. Sites 3 through 6 ask a different question: do the next dots on the map land next to each other, or spread across new markets?
The decision gets made in real estate language, but it commits you to having a clear vision for your staffing model, your capital plan, and the narrative you'll raise on next. The common narrative is that to prove your model, it needs to work across multiple geographies. I've watched operators choose spread because the pitch deck map looked better with five metros on it, then spend two years paying for that slide.
What does clinic density actually buy you?
Putting clinics 20 minutes apart in one metro has financial and operational benefits that don't show up in a site-by-site pro forma.
Staffing stops being binary. With one clinic, a sick MA is a closed-room day and a rescheduling cascade. With three clinics inside a float radius, it's a schedule adjustment. The float pool is the single most underrated argument for density. Clinical labor is your largest operating cost and your most volatile one, and density is the only real estate strategy that de-risks it.
Builds get cheaper and faster on repetition. Your third build in the same jurisdiction uses the same architect, the same GC, and a plan reviewer who has seen your drawings twice before. I've watched build #3 in a known jurisdiction come in 15 to 20 percent faster than build #1 beacuse of familiarity of all parties with your model and expectations. A new market resets that clock to zero.
Management span stays drivable. One regional manager covers four or five clinics in a metro. Spread the same five clinics across five cities and that role becomes a travel schedule with a salary (and travel expenses) attached. Clinics get walked monthly instead of weekly.
Brand and payers compound locally. Referral relationships, marketing spend, and word of mouth all operate inside one media market. And a meaningful share of covered lives in one metro changes the tone of payer contract conversations in a way that five 2-percent positions in five metros never will.
What does spreading into new markets buy you?
Density is the operator's answer. Spread is sometimes the company's answer, and dismissing it as vanity is its own mistake.
A multi-market proof point. If your next raise depends on a national story, two markets that both work is evidence one market can't provide. Investors have seen plenty of single-metro businesses that turned out to be one good market wearing a platform costume.
Concentration risk comes off the table. One payer exiting, one health system opening across the street, one city slowing its permit counter. In a single-metro portfolio, any of these hits every site at once.
Moats, where they exist. In segments where licensure, certificate-of-need rules, or scarce compliant real estate create durable first-mover positions, getting there early matters more than operating density. PACE service areas are the clearest case. Sometimes the land grab is the strategy.
What does opening in a new market really cost?
Here's what the five-city map costs. Every new market re-runs the first-clinic learning curve: a new permitting authority with its own rhythm, a new broker, (often) a new GC and architect, new payer contracts, a new labor pool, new vendors. In The Coordination System I mapped where 25 percent of timeline and budget disappears: the seams between specialists. A new market multiplies the seams, because every relationship at every seam is new.
Roughly half your playbook travels. The clinical program, the space program, and the brand move cleanly. The other half — jurisdiction knowledge, contractor relationships, payer mechanics, labor market instincts — gets re-purchased in every new market, paid for in months and change orders.
How close is too close when you cluster clinics?
If you densify, the next question is how close is too close. Two drive sheds that touch at the edges relieve each other: overflow, float staff, shared specialists. Two sheds stacked on top of each other split one patient base across two rent checks. My working rule: cannibalization of 10 to 15 percent is acceptable when both sites still clear breakeven and your incumbent site's wait times run past two to three weeks. Cannibalizing a site that has spare capacity means you bought a problem twice.
Density or spread: how do you decide?
Density
- Float pools and staffing resilience
- Faster, cheaper repeat builds
- Drivable management span
- Local brand gravity and payer leverage
- Market concentration risk
- A smaller map on the pitch deck
Spread
- The national narrative
- De-risked concentration
- First-mover moats where rules create them
- The first-clinic curve, re-run per market
- Leadership travel and slower fixes
- Half the playbook re-purchased each time
Density compounds operations. Spread compounds story. The question to put to your board: which one do the next 24 months depend on?
If the next milestone is proving unit economics — and for almost everyone between sites 3 and 6, it is — densify. If you've raised on a national thesis, operate in a moat-rich segment, and have the capital to fund two learning curves at once, spread with your eyes open and budget the new-market tax explicitly, the way I laid out in The Healthcare Growth Algorithm.
The common middle path is a dominant home metro plus one deliberate second market as a portability test. It's defensible, but only if you resource the second market as what it is: a second first-clinic, with a first-clinic's timeline, budget, and attention demands. The version where market #2 gets site #4's budget is the version I get called in to fix.
Key takeaways
- Density compounds operations; spread compounds story. Decide which one the next 24 months depend on.
- Clustering builds a float pool that turns a sick MA from a closed-room day into a schedule adjustment — density is the only real estate strategy that de-risks your largest, most volatile cost.
- Repeat builds in a known jurisdiction run 15 to 20 percent faster than the first; a new market resets that clock to zero.
- Roughly half your playbook travels; the other half — jurisdiction knowledge, contractor relationships, payer mechanics, labor instincts — gets re-purchased in months and change orders.
- When you densify, keep cannibalization to 10 to 15 percent and overlap drive sheds only when the incumbent's wait times already run past two to three weeks.
Frequently asked questions
Should I cluster clinics in one market or expand into new ones?
For most operators between sites 3 and 6, density wins. Clustering in one metro compounds staffing float pools, faster and cheaper repeat builds, drivable management, and local payer leverage. Spread into new markets only if your next raise depends on a national story, you operate in a moat-rich segment, or you have the capital to fund two first-clinic learning curves at once.
What does opening in a new healthcare market actually cost?
Every new market re-runs the first-clinic learning curve: a new permitting authority, new GC and architect, new broker, new payer contracts, a new labor pool, and new vendors. Roughly half your playbook travels — clinical program, space program, brand. The other half is re-purchased in months and change orders, and the new market multiplies the coordination seams where timeline and budget disappear.
How close together can I place two clinics without cannibalizing them?
My working rule: cannibalization of 10 to 15 percent is acceptable when both sites still clear breakeven and your incumbent site's wait times already run past two to three weeks. Two drive sheds that touch at the edges relieve each other through overflow and shared staff. Two sheds stacked directly on top of each other just split one patient base across two rent checks.
When does spreading into new markets make sense?
Spread makes sense when you've raised on a national thesis and need a multi-market proof point, when concentration risk in a single metro is unacceptable, or when licensure, certificate-of-need rules, or scarce compliant real estate create durable first-mover moats — PACE service areas are the clearest case. Otherwise, densify to prove unit economics first, and budget the new-market tax explicitly.
Mapping Sites 3 Through 6?
I help multi-site healthcare operators pressure-test the density-versus-spread call against staffing, capital, and payer reality — before the LOIs go out.
Schedule a Strategy Session